Retraction Note to: Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1

Affiliations

¹ Department of Gynecology, Jining No. 1 People's Hospital, Jining, Shandong, China.
² Department of Interventional Radiology, Qingdao Hospital of Traditional Chinese Medicine, Qingdao, Shandong, China.
³ Department of Interventional Radiology, Jinan Military General Hospital, Jinan, Shandong, China.
⁴ Department of Interventional Radiology, Jining No. 2 People's Hospital, Jining, Shandong, China.
⁵ Department of Oncology, Qingdao Hospital of Traditional Chinese Medicine, Renmin Road 4, Qingdao, 266000, Shandong, China. jianhuazangqdhc@126.com.
⁶ Department of Gynecology, Qingdao Hospital of Traditional Chinese Medicine, Renmin Road 4, Qingdao, 266000, Shandong, China. pingmoqdhc@126.com.

Qian Li et al. Naunyn Schmiedebergs Arch Pharmacol. 2021 Mar.

. 2021 Mar;394(3):575.

doi: 10.1007/s00210-020-02016-8.

¹ Department of Gynecology, Jining No. 1 People's Hospital, Jining, Shandong, China.
² Department of Interventional Radiology, Qingdao Hospital of Traditional Chinese Medicine, Qingdao, Shandong, China.
³ Department of Interventional Radiology, Jinan Military General Hospital, Jinan, Shandong, China.
⁴ Department of Interventional Radiology, Jining No. 2 People's Hospital, Jining, Shandong, China.
⁵ Department of Oncology, Qingdao Hospital of Traditional Chinese Medicine, Renmin Road 4, Qingdao, 266000, Shandong, China. jianhuazangqdhc@126.com.
⁶ Department of Gynecology, Qingdao Hospital of Traditional Chinese Medicine, Renmin Road 4, Qingdao, 266000, Shandong, China. pingmoqdhc@126.com.

No abstract available

Retraction of

Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1.
Li Q, Jiang C, Wang Y, Wei M, Zheng H, Xu Y, Xu X, Jia F, Liu K, Sun G, Zang J, Mo P. Li Q, et al. Naunyn Schmiedebergs Arch Pharmacol. 2019 Dec;392(12):1477-1489. doi: 10.1007/s00210-019-01687-2. Epub 2019 Jul 10. Naunyn Schmiedebergs Arch Pharmacol. 2019. Retraction in: Naunyn Schmiedebergs Arch Pharmacol. 2021 Mar;394(3):575. doi: 10.1007/s00210-020-02016-8. PMID: 31292669 Retracted.

1. Bo L, Shou Y (2018) Amentoflavone suppresses hepatocellu-lar carcinoma by repressing hexokinase 2 expression through inhibiting JAK2/STAT3 signaling. Biomed Pharmacother 107:243–253. - DOI
1. Li Q, Jiang C, Wang Y (2019) Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1. Naunyn-Schmiedeberg's Arch Pharmacol 392:1477–1489. https://doi.org/10.1007/s00210-019-01687-2 - DOI
1. Qiang W, Yi Yan J, Zhang P, Guo Yuqing X, Yong W, Fawei Q, Qingyun Z (2018) Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis. Biomed Pharmacother 104:28–35. - DOI
1. Xiangyang D, Meihua W, Tao Z, Jiapei Y (2019) Physcion 8‐O‐β‐glucopyranoside inhibits testicular germ cell tumors through regulating microRNA‐199a. Anat Rec. https://doi.org/10.1002/ar.24324 - DOI
1. Xiaoping P, Chen W, Yan L, Lida Z, Ti Z (2018) Protective autophagy induced by physcion suppresses hepato-cellular carcinoma cell metastasis by inactivating the JAK2/STAT3 Axis. Life Sci 214:124–135. - DOI